Carolyn Millar is a Senior Lecturer in the department of haematology and a Consultant Haematologist specialising in haemostasis and thrombosis. She is the clinical lead in haemophilia at the Hammersmith hospital. Dr Millar completed undergraduate medical training at the University of Newcastle-upon-Tyne, graduating with honours. She undertook postgraduate medical training at University College London, the National Hospital for Neurology & Neurosurgery, Queen Square, and St George’s Hospital, Tooting. Dr Millar’s haematology training was largely undertaken at the Hammersmith, Great Ormond Street and Royal Free hospitals, where her doctoral thesis investigated the role of glycans in von Willebrand factor clearance and their relation to von Willebrand disease. Dr Millar has continued to study the configuration, function and kinetics of von Willebrand factor since being awarded a HEFCE clinical senior lectureship to start her position at Imperial College in December 2008. As well as von Willebrand disease, her clinical interests include obstetric haemostasis, rare bleeding disorders, haemophilia and anticoagulant therapy. Dr Millar chairs the UK working party on von Willebrand disease and has led on the UK surveillance of vCJD in patients with bleeding disorders since 2002.
Dr Millar holds a variety of leadership and senior teaching positions at Imperial College and supervises postdoctoral research fellows, MSc., BSc., MD and PhD students. Between 2012 and 2019 she was course co-director of the intercalated BSc programme in haematology. In 2019 Dr Millar was appointed to the position of haematology lead for Phase I (years 1-3) of the new MBBS curriculum. She is personal tutor to MBBS students throughout Y1-6. In 2013 Dr Millar was awarded an Imperial College Teaching Excellence award and in 2019 she completed a Masters in Education (University Learning and Teaching) with Distinction, and her pedagogical interests include role models and identity development.
Agarwala R, Millar CM, Campbell JP, 2020, Haemostatic disorders in pregnancy, Bja Education, Vol:20, ISSN:2058-5349, Pages:150-157
et al., 2019, Next-generation sequencing for the diagnosis of MYH9-RD: Predicting pathogenic variants, Human Mutation, Vol:41, ISSN:1059-7794, Pages:277-290
et al., 2019, Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia, Orphanet Journal of Rare Diseases, Vol:14, ISSN:1750-1172
et al., 2019, Inherited missense variants that affect GFI1B function do not necessarily cause bleeding diatheses, Haematologica, Vol:104, ISSN:0390-6078, Pages:E260-E264
et al., 2019, Germline selection shapes human mitochondrial DNA diversity, Science, Vol:364, ISSN:0036-8075